| Open Document File Size: 770,28 KBShare Result on Facebook
City Lake Forest / Philadelphia / Faubion / / Company TAP Pharmaceutical Products Inc. / / Country United States / / Event FDA Phase / / Facility Laboratory Findings / / IndustryTerm treatment of GERD symptoms / treatment of non-erosive gastroesophageal reflux disease / / MedicalCondition osteopenia / bronchopulmonary dysplasia / pneumonia / symptomatic GERD / dysphagia / esophagitis / chronic / gastroesophageal reflux / dyskinesia / Apnea / hernia / tremor / non-erosive gastroesophageal reflux disease / vomiting / duodenal ulcers / GERD / Hematemesis / Zollinger-Ellison Syndrome / deficiency / cough / Gastroesophageal reflux disease / infections / esophageal atresia / Drug Abuse Potential/Withdrawal / syndrome / asthma / / Organization Gastrointestinal Drugs Advisory Committee / American Society / FDA / DIVISION OF GASTROENTEROLOGY PRODUCTS MEDICAL / / Person Ali Niak / Nelson Textbook / Drugs Lansoprazole (Prevacid) / Mayo Clin Proc / / Position Physician / OFFICER / HB / eds / / Product thrive / Nexium / ranitidine / Sucralfate / Aciphex / Prevacid / amoxicillin / famotidine / Prilosec / carafate / Lansoprazole / clarithromycin / cimetidine / omeprazole / Protonix / rabeprazole / pantoprazole / metoclopramide / Pediatric Suspension / pediatric / / RadioStation Am 1995 / / Technology Pharmacokinetics / Pharmacodynamics / /
SocialTag |
Errata FDA Briefing Package for Gastrointestinal Drugs Advisory Committee November 5, 2010